It is one thing to be an entrepreneur and it is another to be a compassionate one. Eric Lefkofsky is one of the outstanding and kindhearted entrepreneurs. After critically observing field of medicine, Eric could not help but notice the mess the world is facing due to cancer. With his caring heart and his financial outreaches, he began the journey towards developing a cure for cancer. Though not fully developed thus far, he has managed to come up with an approach that aims at managing the effects of this killer disease through his reputable firm Tempus.
An analysis conducted by Surveillance, Epidemiology and End Results Program indicates that a sizeable percentage of American residents have a history of prior cancer. For this reason, it has become paramount to understand the impact of the findings in enhancing cancer clinical trials, trial, outcomes, and the overall patient experience.
Current records show that the population of cancer survivors is increasing significantly. How is this possible? Well, the nation’s healthcare sector has experienced considerable improvements especially in the area of cancer treatment and screening efforts have intensified. Consequently, victims of the dreaded disease have an additional five to 10 years to enjoy their lives.
Unfortunately, prior cancer survivors are often left out of cancer clinical trials. In as much as they would like to be part of the process, these survivors are left out due to critical cancer treatment decisions. If incorporated, they risk interrupting their initial treatment management plans that are likely to impact on the outcomes of both the trial and their treatment. Nonetheless, efforts to understand prior cancer are being heightened in order to improve trials and disease outcomes.
Eric Lefkofsky, a prolific healthcare entrepreneur, has taken these efforts a notch higher. Eric is the Co-founder and the President of Tempus, a health technology firm that applies advanced technology to treat cancer. In collaboration with doctors, he has been able to acquire data from breast, lung, and pancreatic cancer patients and use it to develop personalized and real-time cancer treatments through innovative genomic sequencing and analysis.
Eric Lefkofsky’s determination to manage cancer has seen him come-up with care plans and treatments that are way better for most the patients. Eric believes in his efforts and is optimistic that the next breakthrough in cancer treatment will originate from his firm.
Visit More : https://www.tempus.com/about-us/